Background. The most significant risk following major hepatectomy is postoperative liver insufficiency. Current preoperative assessment of the future liver remnant relies upon assumptions which may not be valid in the setting of advanced resection strategies. This paper reports the feasibility of the ALIIVE technique which assesses the liver remnant with ICG clearance intraoperatively during vascular exclusion. Methods. 10 patients undergoing planned major liver resection (hemihepatectomy or greater) were recruited. Routine preoperative assessment included CT and standardized volumetry. ICG clearance was measured noninvasively using a finger spectrophotometer at various time points including following parenchymal transection during inflow a...
Objective: The aim of this study was to evaluate interstage liver function in associating liver part...
Tc-99m-mebrofenin hepatobiliary scintigraphy (HBS) was used as a quantitative method to evaluate liv...
Liver resection represents the first choice of treatment for primary and secondary liver malignancie...
Background. The most significant risk following major hepatectomy is postoperative liver insufficien...
Purpose: Liver failure is a major cause of early mortality followinghepatectomy. The future-remnant ...
FP31 – Free Papers 31 (long oral) – Liver: Surgical Outcomes 2: no. FP31-02Background: PRE-hepatect...
Hepatic resection is the therapy of choice for malignant and symptomatic benign hepatobiliary tumors...
Background. There is no agreement regarding the preoperative measurement of liver volumes and the mi...
Hepatic resection is the therapy of choice for malignant and symp-tomatic benign hepatobiliary tumor...
(99m)Tc-mebrofenin-hepatobiliary-scintigraphy (HBS) enables measurement of future remnant liver (FRL...
Background. Hepatectomy, an important treatment modality for liver malignancies, has high perioperat...
Background. Hepatectomy, an important treatment modality for liver malignancies, has high perioperat...
AbstractObjectivePost-hepatectomy liver failure (PHLF) is the major cause of death following liver r...
Postoperative liver dysfunction may lead to morbidity and mortality after liver resection. Preoperat...
<p>ICG-clearance was measured 1 day prior to surgery (Pre OP), on the first postoperative day (POD 1...
Objective: The aim of this study was to evaluate interstage liver function in associating liver part...
Tc-99m-mebrofenin hepatobiliary scintigraphy (HBS) was used as a quantitative method to evaluate liv...
Liver resection represents the first choice of treatment for primary and secondary liver malignancie...
Background. The most significant risk following major hepatectomy is postoperative liver insufficien...
Purpose: Liver failure is a major cause of early mortality followinghepatectomy. The future-remnant ...
FP31 – Free Papers 31 (long oral) – Liver: Surgical Outcomes 2: no. FP31-02Background: PRE-hepatect...
Hepatic resection is the therapy of choice for malignant and symptomatic benign hepatobiliary tumors...
Background. There is no agreement regarding the preoperative measurement of liver volumes and the mi...
Hepatic resection is the therapy of choice for malignant and symp-tomatic benign hepatobiliary tumor...
(99m)Tc-mebrofenin-hepatobiliary-scintigraphy (HBS) enables measurement of future remnant liver (FRL...
Background. Hepatectomy, an important treatment modality for liver malignancies, has high perioperat...
Background. Hepatectomy, an important treatment modality for liver malignancies, has high perioperat...
AbstractObjectivePost-hepatectomy liver failure (PHLF) is the major cause of death following liver r...
Postoperative liver dysfunction may lead to morbidity and mortality after liver resection. Preoperat...
<p>ICG-clearance was measured 1 day prior to surgery (Pre OP), on the first postoperative day (POD 1...
Objective: The aim of this study was to evaluate interstage liver function in associating liver part...
Tc-99m-mebrofenin hepatobiliary scintigraphy (HBS) was used as a quantitative method to evaluate liv...
Liver resection represents the first choice of treatment for primary and secondary liver malignancie...